Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Mycobacterium w - a promising immunotherapeutic intervention for diseases

Stefan K, Gordon R, Rolig A, et al. Frontiers in immunology. 2024;
Download PDF
Publication

The Neurological Impact of Leprosy: Manifestations and Treatment Approaches

Calderone A, Aloisi M, Casella C, et al. Neurology International. 2024;
Download PDF
Publication

A Case of Zoonotic Domestically Acquired Hansen Disease (Leprosy) in the State of Georgia

Nicolle D, Ganz J, Mohr M. National Society for Cutaneous Medicine. SKIN The Journal of Cutaneous Medicine. 2024; 8 (6) : 2016-2020.
Download PDF
Publication

Scleromalacia perforans: a rare and sight-threatening complication of chronic erythema nodosum leprosum

Malhi K, Hanumanthu V, Singh S, et al. Oxford University Press (OUP). Transactions of The Royal Society of Tropical Medicine and Hygiene. 2024;
Publication

Comprehensive pan-genome analysis of Mycobacterium marinum: insights into genomic diversity, evolution, and pathogenicity.

Zhang M, Adroub S, Ummels R, et al. Scientific reports. 2024; 14 (1) : 1-12.
Download PDF
Publication

Impact of histopathological and serological assessments on early diagnosis of leprosy relapse.

Dornelas B, da Costa W, de Abreu J, et al. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 2024;
Publication

Leprosy: Evidence supporting safe diagnosis and monitoring of contacts

Ferreira SMB, da Silva FV, Oliveira JSRD, et al. World Evidence-based Healthcare Day. 2024;
Download PDF
Publication

Leprosy (Hansen’s disease) in the 21st century: A human rights approach oriented by ethics of care

United Nations Human Rights - Office of the High Commissioner . 2024;
Download PDF
Publication

Measuring and Comparing Health System Delays in Leprosy Detection Based on the First Healthcare Service Visit in Tegal Regency, Indonesia

Dharmawan Y, Mawarni A, Dharminto , et al. EDP Sciences. BIO Web of Conferences. 2024;
Download PDF
Practical material

Hansen’s Disease (Leprosy) in the United States of America: A Systematic Review

Jain S. 2024;
Access resource

Pagination

  • Previous page ‹‹
  • Page 45
  • Next page ››
Subscribe to Leprosy (Hansen disease)

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD